key: cord-0789866-6vbseqoh
authors: Song, Tian-Zhang; Han, Jian-Bao; Yang, Xiang; Li, Ming-Hua; Zheng, Yong-Tang
title: Tissue distribution of SARS-CoV-2 in non-human primates after combined intratracheal and intranasal inoculation
date: 2021-02-10
journal: Sci China Life Sci
DOI: 10.1007/s11427-020-1877-4
sha: 3054dbc362685d903137d0c6657d1fca2d093768
doc_id: 789866
cord_uid: 6vbseqoh

nan

Dear Editor, As of 5 July, 2020, approximately 20,162,000 confirmed cases of coronavirus disease 2019 , which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have been reported globally, including an estimated 740,000 deaths. Although the clinical manifestations of COVID-19 are heterogeneous, viral infection and pathological changes in the respiratory system, especially the lungs, still represent common characteristics of COVID-19. The nose, served as the entrance to the respiratory system, seems to produce absent or minimal symptoms of nasal congestion or rhinorrhea during SRAS-CoV-2 infection, while other viral rhinitis (i.e., adenovirus, rhinovirus, influenza virus, etc.) are characterized by typical nasal symptoms, including nasal congestion, rhinorrhea, and sneezing. Recent studies suggest that, despite a lack of other nasal symptoms, anosmia is an important sign of early-stage COVID-19 (Lechien et al., 2020) . In addition, Sungnak et al. (2020) reported that SARS-CoV-2 receptors are highly expressed in nasal epithelial cells together with innate immune genes, suggesting that these cells can be infected by SARS-CoV-2 and may play a potential role in transmitting infection to the rest of the body. Furthermore, based on infection data from young children with ACE2 lower expression in the nasal epithelium, Patel and Verma (2020) found that while COV-ID-19 morbidity is similar between middle-aged adults and younger children, young children with SARS-CoV-2 infection show mild clinical manifestations compared with middle-aged adults. Thus, these results suggest that the importance of nasal infection has been primarily ignored in earlier studies. Moreover, nasal infection may influence SARS-CoV-2 transmission or infectious status in the lungs.

We previously established a successful SARS-CoV-2-infected non-human primate model (Shan et al., 2020; Song et al., 2020) . To evaluate the characteristics of nasal infection in COVID-19, six healthy Chinese rhesus macaques (male, adult, 3-7 kg, <18 years old) were enrolled in this study. Three macaques (No. 15011, 02059, and 04305) were inoculated intratracheally with a 1×10 7 mean tissue culture infective dose (TCID 50 ) SARS-CoV-2 and three macaques (No. 14377, 17007, and 15007) were inoculated with 1×10 7 TCID 50 SARS-CoV-2 intratracheally (60%, 6×10 6 TCID 50 ) and intranasally (40%, 4×10 6 TCID 50 ) ( Figure 1A ). The intratracheal inoculation was achieved using a bronchoscope. Subsequently, 200 μL of viral suspension (2×10 6 TCID 50 ) was respectively injected into the two nostrils using a 1 mL needle-free syringe. All animals were euthanized for tissue collection on the 7th day post infection (7 dpi). As shown in Figure 2B , viral RNA was detected in the nasal tissues of all macaques receiving intratracheal and intranasal inoculation (i.e., No. 14377, 17007, and 15007), whereas those macaques receiving only intratracheal inoculation (i.e., No. 15011, 02059, and 04305) showed negative viral RNA results in the nasal tissues. Subsequently, we divided the macaques into a nasal infection group (marked red) and nasal non-infection group (marked blue). Nose and throat swabs were collected on 1, 3, 5, and 7 dpi. The positive ratios of viral RNA in the nasal infection group were much higher than that in the nasal non-infection group in both swab types ( Figure 1C ), suggesting more virus particles congregated in the upper respiratory tract of macaques with nasal infection. Subsequently, viral loads in seven lobes of the lung were detected to evaluate infectious status in the lower respiratory tract ( Figure 1D ). The ratios of lobes with positive viral RNA were markedly higher in the nose infection group than in the nose non-infection group ( Figure 1E ). In addition, the percentages of lobes with viral loads >200 copies μg -1 RNA were significantly higher in the nose infection group than in the nose non-infection group ( Figure 1E ). These differences in the lungs indicated that nasal infection aggravated viral transmission and replication in the lower respiratory tract, suggesting more severe viral infection in the nasal infection group. As the respiratory tract exhibits obvious continuity and consistency in structure and function, the infectious status relationship between the upper and lower respiratory tract was explored by analyzing the correlation between the ratios of SARS-CoV-2+ swabs and percentages of SARS-CoV-2+ lung lobes. As seen in Figure 1F , infectious status showed positive correlation between the upper and lower respiratory tracts. Therefore, nasal SARS-CoV-2 infection markedly enhanced the number of virus particles in the whole respiratory airway, leading to more severe viral infection in the lungs and wider viral transmission. Zheng et al. (2020) previously established a SARS-CoV-2infected rhesus macaque model via single nasal inoculation. Viral loads could be detected in the kidney, liver, spleen, heart, intestine, testis, brain, spinal cord, and lymph nodes, suggesting that nasal infection with SARS-CoV-2 can induce wide viral dissemination in rhesus macaques. However, the viral loads in the lung tissues were relatively low, ranging from 10 2 to 10 3 copies/100 mg tissue, with peak loads much lower than that in the lymph nodes, trachea, liver, and spleen. In addition, the presence of viral RNA in lung tissue displayed obvious variations among animals. Therefore, SARS- CoV-2 infection via single nasal inoculation showed wide viral dissemination but atypical infection in the lungs, which differs from the clinical manifestations observed in patients with COVID-19. Our results indicate the importance of nasal infection in COVID-19, as summarized in Figure 1G . Single intratracheal inoculation induced heterogeneous lung infection and minimal transmission to the upper respiratory tract. However, nasal and intratracheal infection enhanced the number of virus particles of both the upper and lower respiratory tracts. Thus, the severity of respiratory tract infection enhanced air transmission and induced wide and severe SARS-CoV-2 infection in the lungs, suggesting the occurrence of more severe infectiousness and lung injury in SARS-CoV-2 patients with nasal infection. Therefore, nasal infection may be regarded as an important index to assess the severity of COVID-19. Furthermore, treatments focused on nasal infection, like hypertonic saline nasal irrigation and gargling (Ramalingam et al., 2020) , should be considered as a therapeutic option for COVID-19.

Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study

Nasal ACE2 levels and COVID-19 in children

Hypertonic saline nasal irrigation and gargling should be considered as a treatment option for COVID-19

Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in rhesus macaques

Delayed severe cytokine storm and immune cell infiltration in SARS-CoV-2-infected aged Chinese rhesus macaques

SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes

Virulence and pathogenesis of SARS-CoV-2 infection in rhesus macaques: a nonhuman primate model of COVID-19 progression